CENTRAL NERVOUS SYSTEM INFECTIONS Flashcards
KEY CONCEPTS
CRITICAL STEPS
Early Recognition
Appropriate Diagnostic Evaluation
Administration of Antibiotics
Adjunctive Corticosteroids
MC PATHOGENS
S. Pneumoniae
N. Meningitidis
CLINICAL FEATURES
The classic triad of fever, neck stiffness and altered mental status occurs in <50% of all patients with bacterial meningitis.
MANAGEMENT
- ANTIBIOTICS
EMPIRIC ANTIBIOTICS: CAM
Do not delay antibiotics for CT or LP, if delayed
Ceftriaxone 2 g IV q 12 h
AND
Vancomycin 20-35 mg / kg / dose IV loading dose (max 3000 g)
THEN
15-20 mg/kg IV q 12 h
ADD
Ampicillin 2 g IV q 4 h IF > 50 yrs, Alcoholic, Pregnant, Immunocompromised
ADD
Acyclovir 10 mg / kg / dose IV q 8 hrs IF HSV suspected (negative gram stain, seizure)
EMPIRIC ANTIBIOTICS: PENETRATING HEAD TRAUMA, POST-NEUROSURGICAL, CSF SHUNT
Cefepime 2 g IV q 8 h
AND
Vancomycin 20-35 mg / kg / dose IV loading dose (max 3000 g)
THEN
15-20 mg/kg IV q 12 h
ADD
Ampicillin 2 g IV q 4 h IF > 50 yrs, Alcoholic, Pregnant, Immunocompromised
ADD
Acyclovir 10 mg / kg / dose IV q 8 hrs IF HSV suspected (negative gram stain, seizure)
2, CORTICOSTEROIDS
before or at the time of antibiotics if S. Pneumonea is suspected
Adult: Dexamethasone 10 mg IV q 6 h x 4 days
Children: Dexamethasone 0.6 mg / kg / d divided q 6 h x 4 days
- INVESTIGATIONS
CBC, Blood Cultures x 2 prior to antibiotics
LUMBAR PUNCTURE
LP Contraindications
Infection at the site of the LP
Coagulation abnormalities
Risk of brain herniation
Risk / Benefits:
Post LP Headache - occurs in 10-30%
Infection
Bleeding
Back pain or radicular pain or numbness
CSF opening pressure (if done in left lateral decubitus)
Normal Opening Pressure: 50 - 200 mmH20
Tube 1 - cell count, gram stain, xanthocromia
Tube 2 - protein, glucose
Tube 3 - culture & sensitivity, viral studies
Tube 4 - cell count
CT HEAD
Altered mental status (GCS<10)
CNS Disease (CSF Shunt, Hydrocephalus, mass lesion, stroke, or focal infection)
Focal neurological deficit (excluding cranial nerve palsies)
Papilledema
Seizure (new onset within 1 week)
Immunocompromised (HIV, immunosuppressive therapy)
CLINICAL FEATURES
95% of patients have 2/4 features:
Neck stiffness (Se 70%)
Headache (Se 50%)
Fever (>38 C) OR hypothermia
Altered mental status
Photosensitivity
RISK FACTORS
Age: ≥65 years old, Neonates
Aboriginal groups, Students living in residence
PMHx: Immunocompromised (16%): HIV, DM; hepatic / renal failure; Comorbid Infection: otitis media or sinusitis (25%), mastoiditis, Pneumonia (12%), Endocarditis, Dental Infection
Recent neurosurgery, Head trauma, shunts
Recent travel to area with endemic meningococcal disease (eg. sub-Saharan Africa)
Alcoholism, IVDU
MENINGEAL IRRITATION MANEUVERS
Lay patient flat, no pillows
Lift head, hold for 10 seconds to examin for neck stiffness
Jolt accentuation (Sn 6% Sp 98.9%)
Accentuation of headache by horizontal rotation of the head at a frequency of two to three times per second
Brudzinski (Sn 11%, Sp 93.4%)
Spontaneous flexion of the hips during attempted passive flexion of the neck
Kernig’s (Sn 14.1%, Sp 92.3%)
Inability or reluctance to allow full extension of the knee when the hip is flexed 90 degrees
Nuchal Rigidity (Sn 39.4%, Sp 70.3%)
Peticial Rash (63% meningococcal meningitis)
ISOLATE PATIENT:
Droplet Precautions
N. Meningitidis
Indications: Close contact (> 8 hrs), contact with oral secretions
PROPHYLAXIS
Rifampin
Adults: 600 mg PO q 12 hrs x 2 d
Children: 5-10 mg / kg PO q 12 hrs x 2 d
H. Influenza
Indications: Living in household with >= 1 unvaccinated or incompletely vaccinated child age < 4 yrs old
Rifampin 20 mg / kg / d (max 600 mg / d) for 4 days
Group B Strep in Pregnancy
Indications:
Previous baby with group B Strep Infection
Colonization of the perineum or rectal area at 35 - 37 wk GA
Bacterium in pregnancy high risk features: ROM > 18 h, preterm delivery (<37 wk GA)
DDX: CNS INFECTIONS
Meningitis
-fungal
-tubercular
Encephalitis
-HSV
-Arbovirus
Brain Abscess
Cerebral Malaria
Epidural Abscess
CSF FINDINGS
Bacterial: Turbid, WBC>1000/mm3, ↓Glucose ↑↑Protein, 80-90% neutrophils, +gram stain
Viral: Clear, WBC 10-500/mm3, Nml glucose, Nml protein, -gram stain
TRUE CSF WBC = measured CSF WBC [(CSF RBC x serum WBC)/serum RBC]